Skip to main content

Durlaza News (Page 2)

Health Issue Has Bruce Springsteen Postponing Shows for the Rest of the Year

THURSDAY, Sept. 28, 2023 – Rock star Bruce Springsteen announced Wednesday that he has postponed all of his remaining shows this year as he deals with peptic ulcer disease. Springsteen said he’s c...

Using Meds to Manage Your Arthritis Pain: An Overview

TUESDAY, Sept. 19, 2023 – Millions of Americans suffer from arthritis, and many reach for medication to ease their joint pain and inflammation. The options might seem overwhelming, though. Here, the...

EASD: Low-Dose Aspirin Tied to Lower Risk for New Diabetes in Older Adults

TUESDAY, Sept. 5, 2023 – Aspirin treatment reduces the risk for incident diabetes in older adults, according to a study to be presented at the annual meeting of the European Association for the...

ESC: Adverse Outcomes Increased With Suboptimal Adherence to Aspirin After MI

MONDAY, Aug. 28, 2023 – Suboptimal adherence to aspirin after myocardial infarction (MI) is associated with an increased risk for recurrent MI, ischemic stroke, or death, according to a study...

Aspirin Underused in Secondary Prevention of Cardiovascular Disease

THURSDAY, Aug. 24, 2023 – Aspirin is underused in secondary prevention of cardiovascular disease (CVD), according to a study published online Aug. 22 in the Journal of the American Medical...

Skipping Aspirin After Heart Attack Raises Odds for Recurrence

TUESDAY, Aug. 22, 2023 – If you’ve had a heart attack, your doctor likely told you to take a low-dose aspirin daily to stave off a second heart attack or stroke, but most people don’t follow through ...

FDA Medwatch Alert: Drug Safety Communication: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later

ISSUE: FDA is warning that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby. This can lead to low levels of amniotic fluid surrounding...

FDA Approves Durlaza (aspirin) ER Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

New Haven, CT, September 8th, 2015 – New Haven Pharmaceuticals, Inc. a privately held specialty pharmaceuticals company, today announced that the U.S. Food and Drug Administration (FDA) has approved D...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Durlaza patient information at Drugs.com